Budd, Jeffrey
Cusi, Kenneth
Article History
Accepted: 10 September 2020
First Online: 5 October 2020
Compliance with Ethical Standards
:
: Kenneth Cusi has received research support as principal investigator for the University of Florida from Cirius, Echosens, Inventiva, Novartis, Novo Nordisk, Poxel, and Zydus. KC is a consultant for Allergan, Astra-Zeneca, Axcella, BMS, Boehringer Ingelheim, Coherus, Eli Lilly, Genentech, Gilead, HighTide, Inventiva, Intercept, Ionis, Janssen, Pfizer, Poxel, Prosciento, Madrigal, Novo Nordisk, and Sanofi-Aventis.Jeffrey Budd has no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.